Latest News
-
Boehringer Ingelheim inks USD500M immunology deal with Sitryx to target autoimmune disease
Sitryx stands to receive development, regulatory, and commercialization milestone payments exceeding USD 500 million, alongside tiered royalties on future sales if any drug from the partnership reaches the market.
-
CordenPharma Colorado to scale peptide development at new LEED Gold facility
The LEED Gold-certified facility features flexible laboratory configurations and advanced mechanical and utility systems, enabling researchers to conduct intricate scientific research.
-
NAFDAC warns Nigerians against substandard Indian diagnostic kits
NAFDAC released the public alert following a Notice of Concern from the WHO Prequalification service.
-
Nanologica acquires Ardena’s Syntagon Facility to expand API manufacturing
The site will continue operating as a subsidiary under the Syntagon name, maintaining its established brand presence in the pharmaceutical manufacturing sector.
-
Philips unveils Rembra CT Scanner to transform high-demand medical imaging
The system combines Philips’ most advanced detector technology with AI-powered workflows and industry-leading speed, representing a significant advancement in high-acuity imaging.
-
ADF grants USD9.6M to improve health emergency preparedness in Southern Africa
The project will renovate and equip diagnostic laboratories, wastewater monitoring facilities, and environmental surveillance laboratories across six participating countries.
-
BioDuro expands API production to Taiwan through new joint venture with Cenra
The venture aims to deliver comprehensive active pharmaceutical ingredient (API) services, covering everything from initial development stages through full-scale commercial production.
-
Siemens Healthineers showcases AI-powered Angiography Systems for liver cancer treatment at European Radiology Congress
The company showcased three new angiography platforms—Artis genio, Artis icono.explore, and Artis icono.vision—which harness artificial intelligence to enhance the precision of liver cancer embolization treatments.
-
Roche commits USD484M to boost South Korea’s biopharma ecosystem
The company formalized its commitment with South Korea’s Ministry of Health and Welfare to enhance the bio-healthcare industry by supporting international clinical trials and advancing research for innovative medicines.
-
Abbott’s new CardioMEMS HERO Heart Failure Reader wins FDA approval
Abbott engineered the HERO reader to be 60% lighter than its predecessor, making it practical for daily use and convenient enough for patients to carry during travel.